Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells

Lyndsay V. Rhodes, Melyssa R. Bratton, Yun Zhu, Syreeta L. Tilghman, Shannon E. Muir, Virgilio A. Salvo, Chandra R. Tate, Steven Elliott, Kenneth Nephew, Bridgette M. Collins-Burow, Matthew E. Burow

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The majority of breast cancer cases ultimately become unresponsive to endocrine therapies, and this progression of breast cancer from hormone-responsive to hormone-independent represents an area in need of further research. Additionally, hormone-independent carcinomas are characterized as being more aggressive and metastatic, key features of more advanced disease. Having previously shown the ability of the stromal-cell derived factor-1 (SDF-1)-CXCR4 signaling axis to promote primary tumorigenesis and hormone independence by overexpressing CXCR4 in MCF-7 cells, in this study we further examined the role of SDF-1/CXCR4 in the endogenously CXCR4-positive, estrogen receptor α (ER-α)-positive breast carcinoma cell line, MDA-MB-361. In addition to regulating estrogen-induced and hormone-independent tumor growth, CXCR4 signaling stimulated the epithelial-to-mesenchymal transition, evidenced by decreased CDH1 expression following SDF-1 treatment. Furthermore, inhibition of CXCR4 with the small molecule inhibitor AMD3100 induced CDH1 gene expression and inhibited CDH2 gene expression in MDA-MB-361 cells. Further, exogenous SDF-1 treatment induced ER-α-phosphorylation in both MDA-MB-361 and MCF-7-CXCR4 cells, demonstrating ligand-independent activation of ER-α through CXCR4 crosstalk. qPCR microRNA array analyses of the MDA-MB-361 and MCF-7-CXCR4 cell lines revealed changes in microRNA expression profiles induced by SDF-1, consistent with a more advanced disease phenotype and further supporting our hypothesis that the SDF-1/CXCR4 signaling axis drives ER-α-positive breast cancer cells to a hormone independent and more aggressive phenotype. In this first demonstration of SDF-1-CXCR4-induced microRNAs in breast cancer, we suggest that this signaling axis may promote tumorigenesis via microRNA regulation. These findings represent future potential therapeutic targets for the treatment of hormone-independent and endocrine-resistant breast cancer.

Original languageEnglish
Pages (from-to)2573-2581
Number of pages9
JournalExperimental Cell Research
Volume317
Issue number18
DOIs
StatePublished - Nov 1 2011

Fingerprint

Chemokine CXCL12
Estrogen Receptor alpha
MicroRNAs
Carcinogenesis
Hormones
Breast Neoplasms
MCF-7 Cells
Phenotype
Gene Expression
Cell Line
Epithelial-Mesenchymal Transition
Estrogen Receptors
Estrogens
Phosphorylation
Ligands
Carcinoma
Therapeutics
Growth
Research

Keywords

  • AMD3100
  • Breast carcinoma
  • CXCR4
  • Hormone independence
  • MicroRNA
  • SDF-1

ASJC Scopus subject areas

  • Cell Biology

Cite this

Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells. / Rhodes, Lyndsay V.; Bratton, Melyssa R.; Zhu, Yun; Tilghman, Syreeta L.; Muir, Shannon E.; Salvo, Virgilio A.; Tate, Chandra R.; Elliott, Steven; Nephew, Kenneth; Collins-Burow, Bridgette M.; Burow, Matthew E.

In: Experimental Cell Research, Vol. 317, No. 18, 01.11.2011, p. 2573-2581.

Research output: Contribution to journalArticle

Rhodes, LV, Bratton, MR, Zhu, Y, Tilghman, SL, Muir, SE, Salvo, VA, Tate, CR, Elliott, S, Nephew, K, Collins-Burow, BM & Burow, ME 2011, 'Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells', Experimental Cell Research, vol. 317, no. 18, pp. 2573-2581. https://doi.org/10.1016/j.yexcr.2011.08.016
Rhodes, Lyndsay V. ; Bratton, Melyssa R. ; Zhu, Yun ; Tilghman, Syreeta L. ; Muir, Shannon E. ; Salvo, Virgilio A. ; Tate, Chandra R. ; Elliott, Steven ; Nephew, Kenneth ; Collins-Burow, Bridgette M. ; Burow, Matthew E. / Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells. In: Experimental Cell Research. 2011 ; Vol. 317, No. 18. pp. 2573-2581.
@article{99c79a75eb074155bc68a151846cd957,
title = "Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells",
abstract = "The majority of breast cancer cases ultimately become unresponsive to endocrine therapies, and this progression of breast cancer from hormone-responsive to hormone-independent represents an area in need of further research. Additionally, hormone-independent carcinomas are characterized as being more aggressive and metastatic, key features of more advanced disease. Having previously shown the ability of the stromal-cell derived factor-1 (SDF-1)-CXCR4 signaling axis to promote primary tumorigenesis and hormone independence by overexpressing CXCR4 in MCF-7 cells, in this study we further examined the role of SDF-1/CXCR4 in the endogenously CXCR4-positive, estrogen receptor α (ER-α)-positive breast carcinoma cell line, MDA-MB-361. In addition to regulating estrogen-induced and hormone-independent tumor growth, CXCR4 signaling stimulated the epithelial-to-mesenchymal transition, evidenced by decreased CDH1 expression following SDF-1 treatment. Furthermore, inhibition of CXCR4 with the small molecule inhibitor AMD3100 induced CDH1 gene expression and inhibited CDH2 gene expression in MDA-MB-361 cells. Further, exogenous SDF-1 treatment induced ER-α-phosphorylation in both MDA-MB-361 and MCF-7-CXCR4 cells, demonstrating ligand-independent activation of ER-α through CXCR4 crosstalk. qPCR microRNA array analyses of the MDA-MB-361 and MCF-7-CXCR4 cell lines revealed changes in microRNA expression profiles induced by SDF-1, consistent with a more advanced disease phenotype and further supporting our hypothesis that the SDF-1/CXCR4 signaling axis drives ER-α-positive breast cancer cells to a hormone independent and more aggressive phenotype. In this first demonstration of SDF-1-CXCR4-induced microRNAs in breast cancer, we suggest that this signaling axis may promote tumorigenesis via microRNA regulation. These findings represent future potential therapeutic targets for the treatment of hormone-independent and endocrine-resistant breast cancer.",
keywords = "AMD3100, Breast carcinoma, CXCR4, Hormone independence, MicroRNA, SDF-1",
author = "Rhodes, {Lyndsay V.} and Bratton, {Melyssa R.} and Yun Zhu and Tilghman, {Syreeta L.} and Muir, {Shannon E.} and Salvo, {Virgilio A.} and Tate, {Chandra R.} and Steven Elliott and Kenneth Nephew and Collins-Burow, {Bridgette M.} and Burow, {Matthew E.}",
year = "2011",
month = "11",
day = "1",
doi = "10.1016/j.yexcr.2011.08.016",
language = "English",
volume = "317",
pages = "2573--2581",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Academic Press Inc.",
number = "18",

}

TY - JOUR

T1 - Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells

AU - Rhodes, Lyndsay V.

AU - Bratton, Melyssa R.

AU - Zhu, Yun

AU - Tilghman, Syreeta L.

AU - Muir, Shannon E.

AU - Salvo, Virgilio A.

AU - Tate, Chandra R.

AU - Elliott, Steven

AU - Nephew, Kenneth

AU - Collins-Burow, Bridgette M.

AU - Burow, Matthew E.

PY - 2011/11/1

Y1 - 2011/11/1

N2 - The majority of breast cancer cases ultimately become unresponsive to endocrine therapies, and this progression of breast cancer from hormone-responsive to hormone-independent represents an area in need of further research. Additionally, hormone-independent carcinomas are characterized as being more aggressive and metastatic, key features of more advanced disease. Having previously shown the ability of the stromal-cell derived factor-1 (SDF-1)-CXCR4 signaling axis to promote primary tumorigenesis and hormone independence by overexpressing CXCR4 in MCF-7 cells, in this study we further examined the role of SDF-1/CXCR4 in the endogenously CXCR4-positive, estrogen receptor α (ER-α)-positive breast carcinoma cell line, MDA-MB-361. In addition to regulating estrogen-induced and hormone-independent tumor growth, CXCR4 signaling stimulated the epithelial-to-mesenchymal transition, evidenced by decreased CDH1 expression following SDF-1 treatment. Furthermore, inhibition of CXCR4 with the small molecule inhibitor AMD3100 induced CDH1 gene expression and inhibited CDH2 gene expression in MDA-MB-361 cells. Further, exogenous SDF-1 treatment induced ER-α-phosphorylation in both MDA-MB-361 and MCF-7-CXCR4 cells, demonstrating ligand-independent activation of ER-α through CXCR4 crosstalk. qPCR microRNA array analyses of the MDA-MB-361 and MCF-7-CXCR4 cell lines revealed changes in microRNA expression profiles induced by SDF-1, consistent with a more advanced disease phenotype and further supporting our hypothesis that the SDF-1/CXCR4 signaling axis drives ER-α-positive breast cancer cells to a hormone independent and more aggressive phenotype. In this first demonstration of SDF-1-CXCR4-induced microRNAs in breast cancer, we suggest that this signaling axis may promote tumorigenesis via microRNA regulation. These findings represent future potential therapeutic targets for the treatment of hormone-independent and endocrine-resistant breast cancer.

AB - The majority of breast cancer cases ultimately become unresponsive to endocrine therapies, and this progression of breast cancer from hormone-responsive to hormone-independent represents an area in need of further research. Additionally, hormone-independent carcinomas are characterized as being more aggressive and metastatic, key features of more advanced disease. Having previously shown the ability of the stromal-cell derived factor-1 (SDF-1)-CXCR4 signaling axis to promote primary tumorigenesis and hormone independence by overexpressing CXCR4 in MCF-7 cells, in this study we further examined the role of SDF-1/CXCR4 in the endogenously CXCR4-positive, estrogen receptor α (ER-α)-positive breast carcinoma cell line, MDA-MB-361. In addition to regulating estrogen-induced and hormone-independent tumor growth, CXCR4 signaling stimulated the epithelial-to-mesenchymal transition, evidenced by decreased CDH1 expression following SDF-1 treatment. Furthermore, inhibition of CXCR4 with the small molecule inhibitor AMD3100 induced CDH1 gene expression and inhibited CDH2 gene expression in MDA-MB-361 cells. Further, exogenous SDF-1 treatment induced ER-α-phosphorylation in both MDA-MB-361 and MCF-7-CXCR4 cells, demonstrating ligand-independent activation of ER-α through CXCR4 crosstalk. qPCR microRNA array analyses of the MDA-MB-361 and MCF-7-CXCR4 cell lines revealed changes in microRNA expression profiles induced by SDF-1, consistent with a more advanced disease phenotype and further supporting our hypothesis that the SDF-1/CXCR4 signaling axis drives ER-α-positive breast cancer cells to a hormone independent and more aggressive phenotype. In this first demonstration of SDF-1-CXCR4-induced microRNAs in breast cancer, we suggest that this signaling axis may promote tumorigenesis via microRNA regulation. These findings represent future potential therapeutic targets for the treatment of hormone-independent and endocrine-resistant breast cancer.

KW - AMD3100

KW - Breast carcinoma

KW - CXCR4

KW - Hormone independence

KW - MicroRNA

KW - SDF-1

UR - http://www.scopus.com/inward/record.url?scp=80053572726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053572726&partnerID=8YFLogxK

U2 - 10.1016/j.yexcr.2011.08.016

DO - 10.1016/j.yexcr.2011.08.016

M3 - Article

VL - 317

SP - 2573

EP - 2581

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 18

ER -